Suppr超能文献

北卡罗来纳州肝细胞癌治疗障碍及促进因素的定性评估

Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina.

机构信息

Department of Medicine, Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.

出版信息

PLoS One. 2023 Jun 22;18(6):e0287338. doi: 10.1371/journal.pone.0287338. eCollection 2023.

Abstract

BACKGROUND

Many patients with hepatocellular carcinoma (HCC) never receive cancer-directed therapy. In order to tailor interventions to increase access to appropriate therapy, we sought to understand the barriers and facilitators to HCC care.

METHODS

Patients with recently diagnosed HCC were identified through the University of North Carolina (UNC) HCC clinic or local hospital cancer registrars (rapid case ascertainment, RCA). Two qualitative researchers conducted in-depth, semi-structured interviews. Interviews were audiotaped, transcribed, and coded.

RESULTS

Nineteen interviews were conducted (10 UNC, 9 RCA). Key facilitators of care were: physician knowledge; effective communication regarding test results, plan of care, and prognosis; social support; and financial support. Barriers included: lack of transportation; cost of care; provider lack of knowledge about HCC; delays in scheduling; or poor communication with the medical team. Participants suggested better coordination of appointments and having a primary contact within the healthcare team.

LIMITATIONS

We primarily captured the perspectives of those HCC patients who, despite the challenges they describe, were ultimately able to receive HCC care.

CONCLUSIONS

This study identifies key facilitators and barriers to accessing care for HCC in North Carolina. Use of the RCA system to identify patients from a variety of settings, treated and untreated, enabled us to capture a broad range of perspectives. Reducing barriers through improving communication and care coordination, assisting with out-of-pocket costs, and engaging caregivers and other medical providers may improve access. This study should serve as the basis for tailored interventions aimed at improving access to appropriate, life-prolonging care for patients with HCC.

摘要

背景

许多肝细胞癌 (HCC) 患者从未接受过癌症定向治疗。为了调整干预措施以增加获得适当治疗的机会,我们试图了解 HCC 护理的障碍和促进因素。

方法

通过北卡罗来纳大学 (UNC) HCC 诊所或当地医院癌症登记处(快速病例确定,RCA)确定最近诊断为 HCC 的患者。两名定性研究人员进行了深入的半结构化访谈。访谈进行了录音、转录和编码。

结果

共进行了 19 次访谈(UNC 10 次,RCA 9 次)。护理的主要促进因素包括:医生的知识;有效沟通有关测试结果、护理计划和预后;社会支持;和经济支持。障碍包括:交通不便;医疗费用;提供者对 HCC 的了解不足;预约安排延迟;或与医疗团队沟通不畅。参与者建议更好地协调预约,并在医疗团队中指定一名主要联系人。

局限性

我们主要收集了那些尽管面临他们所描述的挑战但最终能够获得 HCC 护理的 HCC 患者的观点。

结论

这项研究确定了在北卡罗来纳州获得 HCC 护理的主要障碍和促进因素。使用 RCA 系统从各种环境中识别治疗和未治疗的患者,使我们能够捕捉到广泛的观点。通过改善沟通和护理协调、协助自付费用以及让照顾者和其他医疗提供者参与进来,减少障碍可能会改善获得机会。这项研究应该作为针对旨在改善 HCC 患者获得适当、延长生命的护理的针对性干预措施的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7a/10287003/45057792d86d/pone.0287338.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验